Updating results

1859 results

Sort: Relevance | Date

Safe staffing for nursing in adult inpatient wards in acute hospitals (SG1)

This guideline covers organisational and managerial approaches to safe nurse staffing of inpatient wards for people aged 18 and over in acute hospitals. It aims to ensure that patients receive the nursing care they need, regardless of the ward to which they are allocated, the time of the day, or the day of the week.

Safe staffing guideline Published July 2014

Safe midwifery staffing for maternity settings (NG4)

This guideline covers safe midwifery staffing in all maternity settings, including at home, in the community, in day assessment units, in obstetric units, and in units led by midwives (both alongside hospitals and free-standing). It aims to improve maternity care by giving advice on monitoring staffing levels and actions to take if there are not enough midwives to meet the needs of women and babies in the service.

NICE guideline Published February 2015

Otitis media (acute): antimicrobial prescribing (NG91)

This guideline sets out an antimicrobial prescribing strategy for acute otitis media (ear infection). It aims to limit antibiotic use and reduce antimicrobial resistance. Acute otitis media can be caused by viruses or bacteria. It lasts for about a week, and most children get better in 3 days without antibiotics. Serious complications are rare.

Antimicrobial prescribing guideline Published March 2018

Sore throat (acute): antimicrobial prescribing (NG84)

This guideline sets out an antimicrobial prescribing strategy for acute sore throat. It aims to limit antibiotic use and reduce antimicrobial resistance. Acute sore throat is often caused by a virus, lasts for about a week, and most people get better without antibiotics. Withholding antibiotics rarely leads to complications.

Antimicrobial prescribing guideline Published January 2018

Sinusitis (acute): antimicrobial prescribing (NG79)

This guideline sets out an antimicrobial prescribing strategy for acute sinusitis. It aims to limit antibiotic use and reduce antimicrobial resistance. Acute sinusitis is usually caused by a virus, lasts for about 2 to 3 weeks, and most people get better without antibiotics. Withholding antibiotics rarely leads to complications.

Antimicrobial prescribing guideline Published October 2017

Urinary tract infection (recurrent): antimicrobial prescribing (NG112)

This guideline sets out an antimicrobial prescribing strategy for preventing recurrent urinary tract infections in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published October 2018

Pyelonephritis (acute): antimicrobial prescribing (NG111)

This guideline sets out an antimicrobial prescribing strategy for acute pyelonephritis (upper urinary tract infection) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published October 2018

Prostatitis (acute): antimicrobial prescribing (NG110)

This guideline sets out an antimicrobial prescribing strategy for acute prostatitis. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published October 2018

Urinary tract infection (lower): antimicrobial prescribing (NG109)

This guideline sets out an antimicrobial prescribing strategy for lower urinary tract infection (also called cystitis) in children, young people and adults who do not have a catheter. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published October 2018

Diabetic foot problems: prevention and management (NG19)

This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.

NICE guideline Published August 2015 Last updated October 2019

Cellulitis and erysipelas: antimicrobial prescribing (NG141)

This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published September 2019

Pneumonia (community-acquired): antimicrobial prescribing (NG138)

This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with a confirmed diagnosis of community-acquired pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published September 2019

Cough (acute): antimicrobial prescribing (NG120)

This guideline sets out an antimicrobial prescribing strategy for acute cough associated with an upper respiratory tract infection or acute bronchitis in adults, young people and children. It aims to limit antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published February 2019

Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117)

This guideline sets out an antimicrobial prescribing strategy for managing and preventing acute exacerbations of bronchiectasis (non-cystic fibrosis). It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published December 2018

Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing (NG114)

This guideline sets out an antimicrobial prescribing strategy for acute exacerbations of chronic obstructive pulmonary disease (COPD). It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published December 2018

Urinary tract infection (catheter-associated): antimicrobial prescribing (NG113)

This guideline sets out an antimicrobial prescribing strategy for catheter-associated urinary tract infection in children, young people and adults. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published November 2018

Pneumonia (hospital-acquired): antimicrobial prescribing (NG139)

This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with a confirmed diagnosis of hospital-acquired pneumonia. It does not cover ventilator-associated pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published September 2019

Human and animal bites: antimicrobial prescribing

In development [GID-NG10137] Expected publication date: 30 June 2020

Antimicrobial prescribing guideline In development

Diabetic foot infection: antimicrobial prescribing

In development [GID-NG10132] Expected publication date: 11 October 2019

Antimicrobial prescribing guideline In development

Secondary infection of common skin conditions including eczema: antimicrobial prescribing

In development [GID-NG10135] Expected publication date: 10 November 2020

Antimicrobial prescribing guideline In development

Leg ulcer infection: antimicrobial prescribing

In development [GID-NG10133] Expected publication date: 11 February 2020

Antimicrobial prescribing guideline In development

Impetigo: antimicrobial prescribing

In development [GID-NG10134] Expected publication date: 11 February 2020

Antimicrobial prescribing guideline In development

Clostridium difficile infection: antimicrobial prescribing

In development [GID-NG10144] Expected publication date: 30 September 2020

Antimicrobial prescribing guideline In development

Skin abscess: antimicrobial prescribing

In development [GID-NG10163] Expected publication date: TBC

Antimicrobial prescribing guideline In development

Insect bites and stings: antimicrobial prescribing

In development [GID-NG10136] Expected publication date: 30 June 2020

Antimicrobial prescribing guideline In development

Community nursing care settings

In development [GID-SGWAVE0700] Expected publication date: TBC

Safe staffing guideline In development

Inpatient mental health settings

In development [GID-SGWAVE0701] Expected publication date: TBC

Safe staffing guideline In development

Accident and emergency departments

In development [GID-SGWAVE0762] Expected publication date: TBC

Safe staffing guideline In development

Management and organisational approaches to safe staffing

In development [GID-SGWAVE0761] Expected publication date: TBC

Safe staffing guideline In development

Mental health community settings

In development [GID-SGWAVE0702] Expected publication date: TBC

Safe staffing guideline In development

Blinatumomab for treating Philadelphia-chromosome-positive relapsed or refractory acute lymphoblastic leukaemia [ID1008]

In development [GID-TA10119] Expected publication date: 01 July 2020

Technology appraisal guidance In development

Olaparib for treating BRCA 1 or 2 mutated metastatic breast cancer after prior chemotherapy [ID1382]

In development [GID-TA10342] Expected publication date: 01 July 2020

Technology appraisal guidance In development

Endopyelotomy for pelviureteric junction obstruction (IPG325)

Evidence-based recommendations on endopyelotomy for treating pelviureteric junction (PUJ) obstruction

Interventional procedures guidance Published December 2009

Electrocautery cutting balloon treatment for pelviureteric junction obstruction (IPG324)

Evidence-based recommendations on electrocautery cutting balloon treatment for pelviureteric junction (PUJ) obstruction

Interventional procedures guidance Published December 2009

Balloon catheter insertion for Bartholin's cyst or abscess (IPG323)

Evidence-based recommendations on balloon catheter insertion for treating Bartholin's cyst or abscess

Interventional procedures guidance Published December 2009

Endoscopic transsphenoidal pituitary adenoma resection (IPG32)

Evidence-based recommendations on endoscopic transsphenoidal pituitary adenoma resection for treating pituitary adenomas (benign tumours)

Interventional procedures guidance Published December 2003

Individually magnetic resonance imaging-designed unicompartmental interpositional implant insertion for osteoarthritis of the knee (IPG317)

Evidence-based recommendations on inserting individually MRI-designed unicompartmental, interpositional (customised) implant for knee osteoarthritis

Interventional procedures guidance Published September 2009

Extracorporeal albumin dialysis for acute liver failure (IPG316)

Evidence-based recommendations on extracorporeal albumin dialysis for acute liver failure

Interventional procedures guidance Published September 2009

Extracorporeal shockwave therapy for refractory tennis elbow (IPG313)

Evidence-based recommendations on extracorporeal shockwave (inaudible sound waves) therapy for refractory tennis elbow

Interventional procedures guidance Published August 2009

Extracorporeal shockwave therapy for refractory plantar fasciitis (IPG311)

Evidence-based recommendations on extracorporeal shockwave therapy for refractory plantar fasciitis (ligament deterioration between the heel and foot)

Interventional procedures guidance Published August 2009

Placement of pectus bar for pectus excavatum (also known as MIRPE or the Nuss procedure) (IPG310)

Evidence-based recommendations on placing a pectus bar (MIRPE/the Nuss procedure) to treat pectus excavatum (‘funnel chest’)

Interventional procedures guidance Published August 2009

Endoscopic laser foraminoplasty (IPG31)

Evidence-based recommendations on endoscopic laser foraminoplasty for treating back pain caused by a prolapsed intervertebral disc

Interventional procedures guidance Published December 2003

Interstitial laser therapy for breast cancer (IPG89)

Evidence-based recommendations on interstitial laser therapy for treating breast cancer

Interventional procedures guidance Published September 2004

Photodynamic therapy for advanced bronchial carcinoma (IPG87)

Evidence-based recommendations on photodynamic therapy to treat bronchial carcinoma (non-small cell lung cancer/NSCLC)

Interventional procedures guidance Published August 2004

Endovascular atrial septostomy (IPG86)

Evidence-based recommendations on endovascular atrial septostomy for cyanotic congenital heart disease in babies

Interventional procedures guidance Published August 2004

Stereotactic radiosurgery for trigeminal neuralgia using the gamma knife (IPG85)

Evidence-based recommendations on stereotactic radiosurgery using the gamma knife to treat trigeminal neuralgia (nerve pain in the face)

Interventional procedures guidance Published August 2004

Supraorbital minicraniotomy for intracranial aneurysm (IPG84)

Evidence-based recommendations on supraorbital minicraniotomy for intracranial aneurysm (cerebral aneurysm)

Interventional procedures guidance Published August 2004

Selective peripheral denervation for cervical dystonia (IPG80)

Evidence-based recommendations on selective peripheral denervation for treating cervical dystonia

Interventional procedures guidance Published August 2004

Radiofrequency ablation of varicose veins (IPG8)

Evidence-based recommendations on radiofrequency ablation of varicose veins

Interventional procedures guidance Published September 2003

Stent placement for vena caval obstruction (IPG79)

Evidence-based recommendations on stent placement for vena caval obstruction

Interventional procedures guidance Published July 2004